Global D Dimer Testing Market Share, Growth, Drivers, Price, And Key Manufacturers | Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH

The D Dimer Testing Global Market Report 2023, provides comprehensive information on the d dimer testing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The D Dimer Testing Market’s Growth:

According to The Business Research Company’s Global Market Report for D Dimer Testing in 2023, the market is poised for robust growth, projected to ascend from $1.3 billion in 2022 to $1.38 billion in 2023, reflecting a noteworthy compound annual growth rate (CAGR) of 6%. However, the landscape has been significantly shaped by the tumultuous events surrounding the Russia-Ukraine war, introducing complexities that have impacted global economic recuperation from the COVID-19 pandemic.

The repercussions of the conflict have manifested in the form of economic sanctions on numerous nations, an upsurge in commodity prices, and disruptions in global supply chains. These multifaceted challenges have collectively given rise to inflationary pressures across a spectrum of goods and services, exerting influence on diverse markets worldwide. In the context of d-dimer testing, the market is anticipated to attain a valuation of $1.67 billion by 2027, propelled by a CAGR of 4.9%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

A discernible trend steering the trajectory of the d-dimer testing domain is the prevalence of product innovations. Key industry players are strategically embracing innovation to fortify their market standing. Notably, major companies in this space are channeling efforts into the development of groundbreaking products. A noteworthy example is CTK Biotech Inc., a prominent US-based biotechnology company. In September 2020, the company unveiled the RaFIA immunofluorescence immunoassay system, representing a paradigm shift in quantitative testing methodologies.

The RaFIA system distinguishes itself by offering a rapid test characterized by ease of use, heightened sensitivity, and an expansive working range. Complemented by the RaFIA Test and the immunofluorescence analyzer and incubator, this comprehensive system constitutes a closed-loop mechanism. The closed system design ensures accuracy, expedites testing procedures, exhibits flexibility, and prioritizes user-friendliness. This strategic foray into innovative solutions underscores the commitment of industry leaders to not only meet but exceed the evolving demands of the d-dimer testing landscape.

The d dimer testing market is segmented:
1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Top 5 Major Players:

North America was the largest region in the d dimer testing market in 2022.

Table of contents :
1. Executive Summary
2. D Dimer Testing Market Characteristics
3. D Dimer Testing Market Trends And Strategies
4. D Dimer Testing Market – Macro Economic Scenario
5. Global D Dimer Testing Market Size and Growth


32. Global D Dimer Testing Market Competitive Benchmarking
33. Global D Dimer Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The D Dimer Testing Market
35. D Dimer Testing Market Future Outlook and Potential Analysis
36. Appendix

List Of Tables:
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global D Dimer Testing Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global D Dimer Testing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global D Dimer Testing Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion


Table 76: Kaiser Foundation Health Plan Inc. Financial Performance
Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
Table 78: Thermo Fisher Scientific Inc. Financial Performance
Table 79: Abbott Laboratories Financial Performance
Table 80: Siemens Healthcare GmbH Financial Performance

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Related Reports:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
Healthcare Blog:
Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *